Latest Breaking News On - Bernard escudier - Page 1 : comparemela.com

ASCO GU 2023: Nivolumab plus Cabozantinib vs Sunitinib for First-Line Treatment of Advanced RCC: 3-Year Follow-up from the Phase 3 CheckMate 9ER Trial

ASCO GU 2023: Nivolumab plus Cabozantinib vs Sunitinib for First-Line Treatment of Advanced RCC: 3-Year Follow-up from the Phase 3 CheckMate 9ER Trial
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoSaby georgeAmishi yogesh shahCarlosh barriosHoward gurneyBernard escudierCamillo portaJens bedkePeter wangThomas powlesMaria teresa bourlonZachary klaassenViktor fedorovMauricio burottoYoshihiko tomita

Bristol Myers Squibb Research at ESMO Congress 2022 Highlights Depth of Development Program Across Early- and Late-Stages of Cancer

05.09.2022 - Bristol Myers Squibb (NYSE: BMY) today announced the presentation of scientific research across several solid tumors showcasing the breadth of the Company’s oncology development program at the European Society for Medical Oncology (ESMO) Congress .

United statesSouth koreaTabitha chanFadi diabDavid cellaSaby georgeIsabelle borgetJames larkinAnne rogiersBernard escudierLe tourneauChrisann kyiDanielm geynismanBristol myers squibbNazir tannirMarie sylivie

Avastin wins EU approval for advanced renal cancer

The CHMP issues a positive recommendation for Roche s cancer drug Avastin for use in first-line therapy of advanced renal cell carcinoma

France generalBernard escudierInstitut gustave roussyEuropean committeeMedicinal productsHuman useSwiss based rocheInnovative therapy unitAvastin wins eu approval for advanced renal cancerHe chmp issuesa positive recommendation for roches cancer drug avastin use in first line therapy of advanced renal cell carcinomaNews article

EIKCS 2022: Nivolumab + Ipilimumab + Cabozantinib for Previously Untreated Advanced RCC: Results from a Discontinued Study Arm of CheckMate 9ER

EIKCS 2022: Nivolumab + Ipilimumab + Cabozantinib for Previously Untreated Advanced RCC: Results from a Discontinued Study Arm of CheckMate 9ER
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalZachary klaassenBernard escudierInstitut gustave roussyInternational kidney cancer symposiumGeorgia cancer centerAugusta university medical college of georgiaKidney cancer symposiumEuropean annualMedical oncologistUrologic oncologistAssistant professorMedical collegeEurope annual hybrid meetingAdvanced renal cell

EIKCS 2022: The Pieter de Mulder Award Lecture

EIKCS 2022: The Pieter de Mulder Award Lecture
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalDana farber cancer instituteChristopher jd wallisBernard escudierToni choueiriGustav rouseyInstitut gustave roussyTom powlesLaurence albigesLank centerUniversity of torontoInternational kidney cancer symposiumCancer centerKidney cancer symposiumPieter de mulder award